CollPlant Biotechnologies (CLGN) Long-Term Deferred Tax (2020 - 2022)
CollPlant Biotechnologies' (CLGN) quarterly Long-Term Deferred Tax came in at $23.1 million in Q4 2022, up 39.98% YoY from $16.5 million in Q4 2021, and up 39.98% on a QoQ basis from $16.5 million in Q4 2021.
CollPlant Biotechnologies (CLGN) Long-Term Deferred Tax (2020 - 2022) Analysis & Trends
CollPlant Biotechnologies (CLGN) has 3 years of Long-Term Deferred Tax data on file, last reported at $23.1 million in Q4 2022.
- Quarterly Long-Term Deferred Tax rose 39.98% year-over-year to $23.1 million in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $23.1 million (up 39.98% YoY) and the FY2022 annual result came in at $23.1 million, up 39.98% from the prior year.
- Long-Term Deferred Tax improved to $23.1 million in Q4 2022, from $16.5 million in the prior quarter.
- In the past five years, Long-Term Deferred Tax ranged from a high of $23.1 million in Q4 2022 to a low of $15.5 million in Q4 2020.
- A 3-year average of $18.4 million and a median of $16.5 million in 2021 frame the typical range for Long-Term Deferred Tax.
- Annual changes were most pronounced in 2021 — Long-Term Deferred Tax climbed 6.38% — and 2022, when it soared 39.98%.
- Tracing CLGN's Long-Term Deferred Tax over 3 years: stood at $15.5 million in 2020, then advanced by 6.38% to $16.5 million in 2021, then soared by 39.98% to $23.1 million in 2022.
- The last three Long-Term Deferred Tax figures came in at $23.1 million (Q4 2022), $16.5 million (Q4 2021), and $15.5 million (Q4 2020), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | CollPlant Biotechnologies | 4.26 Mn | 4.26 Mn | -243,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 23.09 Mn |
| Dec 31, 2021 | 16.50 Mn |
| Dec 31, 2020 | 15.51 Mn |